Cargando…

The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary

The aim of our study was to examine the involvement of renin-angiotensin system (RAS) in estrogen-induced lactotropes proliferation and vascular endothelial growth factor (VEGF) expression in rat pituitary. The study was performed on Fisher 344 rats underwent 8-day treatment with diethylstilboestrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawnicka, Hanna, Ptasinska-Wnuk, Dorota, Mucha, Slawomir, Kunert-Radek, Jolanta, Pawlikowski, Marek, Stepien, Henryk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360946/
https://www.ncbi.nlm.nih.gov/pubmed/22645419
http://dx.doi.org/10.1100/2012/358102
_version_ 1782234065934483456
author Lawnicka, Hanna
Ptasinska-Wnuk, Dorota
Mucha, Slawomir
Kunert-Radek, Jolanta
Pawlikowski, Marek
Stepien, Henryk
author_facet Lawnicka, Hanna
Ptasinska-Wnuk, Dorota
Mucha, Slawomir
Kunert-Radek, Jolanta
Pawlikowski, Marek
Stepien, Henryk
author_sort Lawnicka, Hanna
collection PubMed
description The aim of our study was to examine the involvement of renin-angiotensin system (RAS) in estrogen-induced lactotropes proliferation and vascular endothelial growth factor (VEGF) expression in rat pituitary. The study was performed on Fisher 344 rats underwent 8-day treatment with diethylstilboestrol (DES). The proliferation index (PCNA) and VEGF expression in pituitary sections were estimated using immunohistochemical methods. Treatment with DES increased the number of PCNA-positive cells, VEGF-positive cells, and VEGF-positive blood vessels in pituitary. Stimulatory effect of estrogen on cell proliferation and VEGF expression in blood vessels was attenuated by losartan, PD123319, and captopril. VEGF immunoreactivity in pituitary cells of DES-treated rats was decreased by AT1 antagonist and not changed by AT2 blocker and ACE inhibitor. Our findings suggest the involvement of RAS in DES-induced cell proliferation and VEGF expression in pituitary. Both the AT1 and AT2 receptors appear to mediate the estrogen-dependent mitogenic and proangiogenic effects in rat pituitary.
format Online
Article
Text
id pubmed-3360946
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Scientific World Journal
record_format MEDLINE/PubMed
spelling pubmed-33609462012-05-29 The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary Lawnicka, Hanna Ptasinska-Wnuk, Dorota Mucha, Slawomir Kunert-Radek, Jolanta Pawlikowski, Marek Stepien, Henryk ScientificWorldJournal Research Article The aim of our study was to examine the involvement of renin-angiotensin system (RAS) in estrogen-induced lactotropes proliferation and vascular endothelial growth factor (VEGF) expression in rat pituitary. The study was performed on Fisher 344 rats underwent 8-day treatment with diethylstilboestrol (DES). The proliferation index (PCNA) and VEGF expression in pituitary sections were estimated using immunohistochemical methods. Treatment with DES increased the number of PCNA-positive cells, VEGF-positive cells, and VEGF-positive blood vessels in pituitary. Stimulatory effect of estrogen on cell proliferation and VEGF expression in blood vessels was attenuated by losartan, PD123319, and captopril. VEGF immunoreactivity in pituitary cells of DES-treated rats was decreased by AT1 antagonist and not changed by AT2 blocker and ACE inhibitor. Our findings suggest the involvement of RAS in DES-induced cell proliferation and VEGF expression in pituitary. Both the AT1 and AT2 receptors appear to mediate the estrogen-dependent mitogenic and proangiogenic effects in rat pituitary. The Scientific World Journal 2012-04-26 /pmc/articles/PMC3360946/ /pubmed/22645419 http://dx.doi.org/10.1100/2012/358102 Text en Copyright © 2012 Hanna Lawnicka et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lawnicka, Hanna
Ptasinska-Wnuk, Dorota
Mucha, Slawomir
Kunert-Radek, Jolanta
Pawlikowski, Marek
Stepien, Henryk
The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_full The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_fullStr The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_full_unstemmed The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_short The Involvement of Angiotensin Type 1 and Type 2 Receptors in Estrogen-Induced Cell Proliferation and Vascular Endothelial Growth Factor Expression in the Rat Anterior Pituitary
title_sort involvement of angiotensin type 1 and type 2 receptors in estrogen-induced cell proliferation and vascular endothelial growth factor expression in the rat anterior pituitary
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360946/
https://www.ncbi.nlm.nih.gov/pubmed/22645419
http://dx.doi.org/10.1100/2012/358102
work_keys_str_mv AT lawnickahanna theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT ptasinskawnukdorota theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT muchaslawomir theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT kunertradekjolanta theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT pawlikowskimarek theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT stepienhenryk theinvolvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT lawnickahanna involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT ptasinskawnukdorota involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT muchaslawomir involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT kunertradekjolanta involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT pawlikowskimarek involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary
AT stepienhenryk involvementofangiotensintype1andtype2receptorsinestrogeninducedcellproliferationandvascularendothelialgrowthfactorexpressionintheratanteriorpituitary